← FDA DRUG APPROVALS

FDA ANDA · ANDA206211

POTASSIUM IODIDE

Sponsor: MISSION PHARMACAL

APPLICATION
ANDA206211
TYPE
ANDA
ORIGINAL APPROVAL
2016-03-24
LATEST ACTION
2016-03-24
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Over-the-counter

Products

POTASSIUM IODIDEOver-the-counter
POTASSIUM IODIDE 65MG/ML · SOLUTION · ORAL

Approval history

2016-03-24UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →